Jump to content

Ramipril

Ɛfi Wikipedia
Wɔatwerɛ nsɛm wei ɛwɔ Asante kasa mu

Ramipril, a Altace ne ɛbinom na wɔtɔn no, yɛ aduro a wɔde hwɛ mogyaborosoɔ,akomayareɛ, ne sawa mu yareɛ.[1] [2]Wɔtumi de di dwuma sɛ akwansideɛ aduro wɔ wɔn wɔadi boro mfeɛ aduonunum sɛdeɛ ɛbɛyɛ a wɔnya akomayareɛ, nnwodwoɔ anaa sɛ owuo wɔ nnipa a wɔwɔ yareɛ bi te sɛ asikyireyareɛ ne wɔn a wɔwɔ yareɛ binom.

Yareɛ A Wɔde Sa

[sesa]

Yareɛ a wɔde sa no bi ne:

  • Akoma a ɛntumi nyɛ adwuma yie
  • Nnipa a wɔwɔ akomayareɛ
  • Ɛyɛ hu wɔ wɔn a wɔadi mfeɛ boro aduonunum: wɔde si akomayareɛ ano,nnwodwoɔ, owuo.

Nsunsuansoɔ

[sesa]
  • Awosoɔ
  • Ɛwa
  • Anisobiri ne tipaeɛ ɛsiane mogya a ɛnni nipadua no mu nti.
  • Ɔbrɛ, ɛnkanka berɛ a worenyini no
  • Anohoyaa, berɛ a worenyini no
  • Abofono
  • Wobɛ bu ahwe fam
  • Nkekaeɛ ho mpopoeɛ (ɛbi te sɛ, ahoɔhyeɛ wo hanam bɛyɛ wo nwunu,ne menemkuro a ɛbɛba atoatoaso).
  • Wo koko bɛyɛ wo ya

Beaeɛ A Menyaa Mmoa Firiiɛ

[sesa]
  1. Heart Outcomes Prevention Evaluation Study Investigators, S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais (2000-01-20), "Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients", The New England Journal of Medicine, vol. 342, no. 3, pp. 145–153, doi:10.1056/NEJM200001203420301, ISSN 0028-4793, PMID 10639539, retrieved 2024-08-26{{citation}}: CS1 maint: multiple names: authors list (link)
  2. "Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy", The Lancet (in English), vol. 355, no. 9200, pp. 253–259, 2000-01, doi:10.1016/S0140-6736(99)12323-7, retrieved 2024-08-26 {{citation}}: Check date values in: |date= (help)